• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Anemia, Refractory

Anemia, Refractory - 25 Studies Found

Completed : Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Angiodysplasias
:
  • Angiodysplasia
  • Vascular Malformations
  • Gastrointestinal Hem
    : 2015-03-04
    : Drug: Octreotide Two injections of 20 mg will be given monthly.
Terminated : A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.
: Acute Myeloid Leukemia
: 2006-08-11
:
  • Procedure: Two post-remission strategies
  • D

Completed : Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
:
  • Childhood Myelodysplastic Syndromes
  • de Novo Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndromes
  • Drug: thalidomide Given orally

Completed : Tipifarnib in Treating Patients With Myelodysplastic Syndromes
:
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndromes
  • Drug: tipifarnib Given PO

Completed : Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome
:
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndromes
  • Other: flow cytometry Correlat

Recruiting : Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
:
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia in Remission
  • : 2015-09-30
    :
    • Drug: Fludarabine Given IV

Active, not recruiting : Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
:
  • Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
  • Chronic Myelomonocytic Leukemia
  • : 2006-11-09
    :
    • Drug: Cyclosporine Given PO

Completed : Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
:
  • Accelerated Phase Chronic Myelogenous Leukemia
  • Adult Acute Myeloid Leukemia in Remission : 2013-02-07
    :
    • Drug: vorinostat Given PO

Completed : Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome
:
  • Chronic Myelomonocytic Leukemia
  • de Novo Myelodysplastic Syndrome
  • Drug: Azacitidine Given intrav

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.